The present invention relates to methods of treating hepatitis C infection HIV infection AIDS or AIDS-related complex or inhibiting HIV replication by administering a compound of Formula I wherein: X is H or OH; Y is H or OH; R1 is H or halogen (F Cl Br I); R2 is H or halogen (F Cl Br I); R3 is H C1-6 alkyl C1-6 fluoroalkyl or benzyl; R4 is H C1-6 alkyl or benzyl; and R5 is H or C1-6 alkyl; or pharmaceutically acceptable salts thereof to a mammal.

The present invention relates to compositions and methods for prophylactic nutritional supplementation and therapeutic nutritional supplementation. Specifically the composition provides a nutritional supplement with a beneficial increased supplementation of vitamin D and the method involves administering to an individual a composition comprising carotenoids vitamin E vitamin D vitamin C thiamine riboflavin niacin folic acid pyridoxine biotin pantothenic acid cobalamin magnesium manganese zinc se...

The present invention relates to an improved multi-step method for preparing an extract from ginkgo biloba having a reduced content of 4'-O-methyl pyridoxine and/or biflavones wherein the depletion is carried out by filtration over an adsorber resin and/or an ion exchanger and the substances to be removed are retained on the resin. The invention further relates to an extract from ginkgo biloba having a reduced content of 4'-O-methyl pyridoxine and/or biflavones which is obtainable by the method ...

FIELD: chemistry.SUBSTANCE: invention relates to pyridoxine derivatives of general formula,where R-is a hydrogen atom or methyl, Ris a hydrogen atom, methyl, linear, branched or cyclic alkyl or Rand Rtogether form a cyclic alkyl capable of powder second-harmonic generation (SHG).EFFECT: invention can be used in laser technology and communication equipment.1 cl, 1 tbl, 7 ex

The present invention is related to a new process for the preparation of 4-methyloxazole-5-carboxylic ester, which is a valuable intermediate in the synthesis of pyridoxine (vitamin B6). The present invention is also related to a new intermediate for the preparation of 4-methyloxazole-5-carboxylic ester and processes for the preparation thereof.

A dual release oral dosage system/dosage form comprising an immediate release component/composition and a delayed release component/composition is described. Each of the immediate release component/composition and delayed release component/composition comprises one or more of doxylamine, an analog thereof, a derivative thereof, a prodrug thereof, a metabolite thereof and/or a salt thereof, and one or more of pyridoxine, a salt thereof, a metabolite thereof and/or a salt of the metabolite. The du...

A dual release oral dosage system/dosage form comprising an immediate release component/composition and a delayed release component/composition is described. Each of the immediate release component/composition and delayed release component/composition comprises one or more of doxylamine, an analog thereof, a derivative thereof, a prodrug thereof, a metabolite thereof and/or a salt thereof, and one or more of pyridoxine, a salt thereof, a metabolite thereof and/or a salt of the metabolite. The du...

A dual release oral dosage system/dosage form comprising an immediate release component/composition and a delayed release component/composition is described. Each of the immediate release component/composition and delayed release component/composition comprises one or more of doxylamine, an analog thereof, a derivative thereof, a prodrug thereof, a metabolite thereof and/or a salt thereof, and one or more of pyridoxine, a salt thereof, a metabolite thereof and/or a salt of the metabolite. The du...